p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers

Cancer Research

Volumn 67, Issue 7, 2007, Pages 3162-3170

  Pei, Xin Hai ^a   Bai, Feng ^a   Smith, Matthew D ^a   Xiong, Yue ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2C; PROTEIN P27; RETINOBLASTOMA PROTEIN; CDKN2C PROTEIN, MOUSE; MEN1 PROTEIN, MOUSE; ONCOPROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; GENE INTERACTION; GENE REPRESSION; GENETIC HETEROGENEITY; LUNG ALVEOLUS CELL; LUNG NON SMALL CELL CANCER; MULTIPLE ENDOCRINE NEOPLASIA; NEUROSECRETORY CELL; NONHUMAN; PENETRANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STEM CELL; ANIMAL; C57BL MOUSE; EPITHELIUM CELL; FEMALE; GENETICS; INBREEDING; LUNG TUMOR; MALE; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN-DEPENDENT KINASE INHIBITOR P18; EPITHELIAL CELLS; FEMALE; GENES, TUMOR SUPPRESSOR; INBREEDING; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MUTATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; STEM CELLS;

EID: 34248154130     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4517     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Meuwissen R, Berns A. Mouse models for human lung cancer. Genes Dev 2005;19:643-64.
3. Spiegel AM. Focus on hereditary endocrine neoplasia Cancer Cell 2004;6:327-32.
4. Chandrasekharappa S, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-7.
5. Stewart C, Parente F, Piehl F, et al. Characterization of the mouse Men1 gene and its expression during development. Oncogene 1998;17:2485-93.
6. Marx SJ. Multiple endocrine neoplasia type 1. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. Columbus, OH: McGraw-Hill; 1998. 489-506.
7. Crabtree JS, Scacheri PC, Ward JM, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A 2001;98:1118-23.
8. Bertolino P, Tong WM, Galendo D, Wang ZQ, Zhang CX. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol 2003;17:1880-92.
9. Bai F, Pei XH, Godfrey VL, Xiong Y. Haploinsufficiency of p18INK4c sensitizes mice to carcinogen-induced tumorigenesis. Mol Cell Biol 2003;23:1269-77.
10. Franklin DS, Godfrey VL, Lee H, et al. CDK inhibitors p18INK4c and p27KIP1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 1998;12:2899-911.
11. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 2000;20: 6147-58.
12. Sanchez-Aguilera A, Delgado J, Camacho FI, et al. Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas. Blood 2004;103:2351-7.
13. Buchwald PC, Akerstrom G, Westin G. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism. Clin Endocrinol (Oxf) 2004;60:389-93.
14. Morishita A, Masaki T, Yoshiji H, et al. Reduced expression of cell cycle regulator p18INK4C in human hepatocellular carcinoma. Hepatology 2004; 40:677-86.
15. Uziel T, Zindy F, Xie S, et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev 2005;19:2656-67.
16. +/- mice. Proc Natl Acad Sci U S A 1999;96:3916-21.
17. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85:707-20.
18. Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 1996;85:721-32.
19. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice. Cell 1996;85:733-44.
20. Sotillo R, Dubus P, Martin J, et al. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J 2001;20:6637-47.
21. Bai F, Pei XH, Nishikawa T, Smith MD, Xiong Y. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors. Mol Cell Biol 2007;27:1495-504.
22. Nikitin AY, Alcaraz A, Anver MR, et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res 2004;64:2307-16.
23. Kitagawa M, Higashi H, Jung HK, et al. The consensus motif for phosphorylation by cyclin D1-4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 1996;15:7060-9.
24. Zarkowska T, US, Harlow E, Mittnacht S. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs. Oncogene 1997;14:249-54.
25. 1-phase inhibitor, p18INK4C. Nat Cell Biol 2004;6:436-42.
26. Otto WR. Lung epithelial stem cells. J Pathol 2002; 197:527-35.
27. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-35.
28. Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 2002;161:173-82.
29. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 2003; 4:181-9.
30. Ward JM, Singh G, Katyal SL, Anderson LM, Kovatch RM. Immunocytochemical localization of the surfactant apoprotein and Clara cell antigen in chemically induced and naturally occurring pulmonary neoplasms of mice. Am J Pathol 1985;118:493-9.
31. Mason RJ, Kalina M, Nielsen LD, Malkinson AM, Shannon JM. Surfactant protein C expression in urethane-induced murine pulmonary tumors. Am J Pathol 2000;156:175-82.
32. Palmer KC. Clara cell adenomas of the mouse lung Interaction with alveolar type 2 cells. Am J Pathol 1985; 120:455-63.
33. Kauffman SL. Histogenesis of the papillary Clara cell adenoma. Am J Pathol 1981;103:174-80.
34. Ten Have-Opbroek AA, Benfield JR, van Krieken JH, Dijkman JH. The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histol Histopathol 1997;12: 319-36.
35. Burke LM, Rush WI, Khoor A, et al. Alveolar adenoma: a histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. Hum Pathol 1999;30:158-67.
36. Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001;15:3243-8.